This educational site for healthcare professionals may refer to drug classes where Teva has a product and/or Teva products. This educational site for healthcare professionals has been initiated and funded by Teva. Prescribing information is available here
Adverse events should be reported: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or telephone +44 (0)207 540 7117, or email uk.safety@tevauk.com.

0 UK head start slim banner 1440x130px.png

Optimising the management, treatment and care for headache and migraine patients

Our Head Start programme activities are created by healthcare professionals, for healthcare professionals - designed for Consultants, Nurses, GPs and other healthcare professionals from the UK and Ireland with an interest in headache and migraine

Latest Updates

On Demand Recordings

Access on-demand recordings from Head Start's Annual Meeting 2024, presented by leading HCPs

Read more

Upcoming Webinar: 12 December

The migraine, anxiety and depression cycle: Could CGRP inhibitors break it?

Register now

Head Start's Annual Meeting

Held in June 2024, you can access the highlights and review the topics covered below

Read more

Next event

Webinar - Thursday 12th December at 13:00

Join chair Dr Jessica Briscoe and speaker Dr Giorgio Lambru for an interactive discussion on psychiatric comorbidities associated with migraine. Sharing patient case studies on how CGRP inhibitors could help them.

Secure your place now by registering below and be at the forefront of optimising care

Register now Webinar - Thursday 12th December at 13:00

This webinar is organised and funded by Teva. Views provided by speakers are their own and not necessarily shared by Teva. Information at the meeting may discuss drug classes where Teva has a product. Prescribing information will be available at the meeting. The event is open to HCPs from the UK with an interest in headache and migraine.

.

Head Start's Annual Meeting 2024

The sixth Head Start educational meeting focused on the latest advancements in headache and migraine management

On Demand Recordings

Access on-demand recordings from Head Start's Annual Meeting 2024

Access Recordings

Agenda & Discussion Topics

Pertinent topics to gain deeper understanding of headache and migraine management strategies

Review Topics

Head Start meetings have been rated highly by previous delegates

100% would attend Head Start's Annual Meeting again*

81% rated the meeting as very successful in hitting their educational objectives*

Meeting was rated 4.9/5 in overall meeting satisfaction*

Read more about Head Start's Annual Meeting 2024

 

Reflections from Head Start's Annual Meeting 2024

Dr Krishna Dani, Consultant Neurologist, NHS Greater Glasgow and Clyde, shares his reflections after Head Start's Annual Meeting 2024

Reflections from Head Start's Annual Meeting 2024

Dr Krishna Dani, Consultant Neurologist, NHS Greater Glasgow and Clyde, shares his reflections after Head Start's Annual Meeting 2024


.

On Demand Recordings

Recordings of Head Start's Annual Meeting 2024 and other related content from Teva

Access on-demand recordings, covering a range of topics from various events, presented by leading healthcare professionals

Find out more Recordings of Head Start's Annual Meeting 2024 and other related content from Teva

.

Hear more from Teva

Keep up to date with upcoming webinars and events

Sign up Hear more from Teva

*of the number of delegates who completed event feedback

Date of preparation: November 2024
Reference: D: MIG-GB-00408 (V1.0) / T: MIG-GB-00409 (V1.0) / M: MIG-GB-00410 (V1.0)